Welcome to LookChem.com Sign In|Join Free
  • or
1-chloro-N-(1-methylethyl)methanesulfonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

52009-26-4

Post Buying Request

52009-26-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52009-26-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 52009-26-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,0 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 52009-26:
(7*5)+(6*2)+(5*0)+(4*0)+(3*9)+(2*2)+(1*6)=84
84 % 10 = 4
So 52009-26-4 is a valid CAS Registry Number.

52009-26-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-chloro-N-propan-2-ylmethanesulfonamide

1.2 Other means of identification

Product number -
Other names Methanesulfonamide,1-chloro-N-(1-methylethyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52009-26-4 SDS

52009-26-4Downstream Products

52009-26-4Relevant academic research and scientific papers

HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

-

Page/Page column 175-176, (2019/08/12)

This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

ISOQUINOLINES AS INHIBITORS OF HPK1

-

Paragraph 1716; 1717, (2018/10/21)

Isoquinoline compounds and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibitng HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 52009-26-4